Navigation Links
Galderma Announces Interim Data Relating to Sequential Treatment Regimen of Clobex(R) Spray Followed by Vectical(TM) Ointment in Managing Plaque Psoriasis
Date:3/6/2009

tment is indicated for the topical treatment of mild to moderate plaque psoriasis in patients 18 years and older. The most frequent adverse events reported in clinical trials (>3%) were lab test abnormality, urine abnormality, psoriasis, hypercalciuria and pruritus. Skin discomfort has also been reported. Vectical(TM) Ointment should be used with caution in patients with known or suspected disturbances in calcium homeostasis, who are taking calcium or Vitamin D supplements, or who are on medications known to increase serum calcium levels, such as thiazide diuretics. If aberrations in parameters of calcium metabolism occur, Vectical(TM) Ointment should be discontinued until these normalize. Patients should be cautioned to avoid excessive exposure to natural or artificial sunlight after applying the ointment. If severe irritation occurs discontinue use. Avoid contact with eyes, lips and face. Vectical(TM) Ointment has not been studied in pregnant or nursing women. Use no more than 200 grams per week.

About Galderma

Galderma, created in 1981 as a joint venture between Nestle and L'Oreal, is a fully integrated specialty pharmaceutical company dedicated exclusively to the field of dermatology. The Company has a presence in 65 countries with over 1000 sales representatives and is committed to improving the health of skin with an extensive line of products across the world that treat a range of dermatological conditions including: acne, rosacea, fungal nail infections, psoriasis & steroid-responsive dermatoses, pigmentary disorders, medical solutions for skin senescence and skin cancers. With a research and development center in Sophia Antipolis, France, Galderma has one of the largest R&D facilities dedicated exclusively to dermatology. Leading worldwide dermatology brands include Differin(R), Epiduo(R), Oracea(R), MetroGel(R) 1%, Rozex(R), Clobex(R), Tri-Luma(R), Loceryl(R) and Cetaphil(R).

For more
'/>"/>

SOURCE Galderma Laboratories, L.P.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Foamix and Galderma to Develop Medicated Foam for Certain Skin Diseases
2. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
3. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
4. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
5. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
8. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
9. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
10. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
11. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... , July 10, 2014  The U.S. Department ... three-year grant to University Hospitals (UH) Case Medical Center ... new national model aimed at improving care for patients ... Care," the project will test a unique model developed ... with late-stage disease, significant comorbidities, or demonstrated need for ...
(Date:7/10/2014)... 2014  BC Technical, the largest nationwide, non-OEM provider ... Inc., a leading provider of Siemens Nuclear Medicine and ... naming BC Technical as the authorized provider of service ... and BC Technical announced today that the two companies ... as the service and systems provider for MiE,s camera ...
(Date:7/10/2014)... , July 10, 2014 CVS Caremark Corporation (NYSE: ... directors has approved a quarterly dividend of $0.275 (27.5 cents) ... payable on August 1, 2014, to holders of record on ... CVS Caremark is dedicated to helping people on their ... in the United States . Through the ...
Breaking Medicine Technology:University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 2University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 3University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services 4BC Technical Partners With MiE America To Be Authorized Provider Of Systems & Service 2
... Inc. (Nasdaq: BDSI ) will host a webcast ... AM Eastern Time to provide a business update which will ... of opioid dependence and an update on the development program ... addition, the webcast will include an update on the ONSOLIS ...
... Sheets: MDBX ) ( www.thedispensingsolution.com ) released ... systems, and the unit,s ability to better regulate and ... According to a recent report from the ... to the emergency room (ER) by nursing facility residents ...
Cached Medicine Technology:BioDelivery Sciences to Host Business Update Webcast and Conference Call on Tuesday, November 15, 2011 at 8:30 AM Eastern Time 2BioDelivery Sciences to Host Business Update Webcast and Conference Call on Tuesday, November 15, 2011 at 8:30 AM Eastern Time 3MedBox Medication Dispensing: Reducing Preventable ER Trips Through Better Medication Management 2
(Date:7/11/2014)... (PRWEB) July 11, 2014 ... email management with its unique Netmail Platform, today ... World Partner Conference (WPC), which will be held ... July 13-17, 2014. During the show, Netmail will ... email management solution that consolidates email security, archiving, ...
(Date:7/10/2014)... 2014 The Capital Institute for Neurosciences ... first procedure in a clinical trial that delivers chemotherapy ... leg. , During the procedure, done at Capital Health ... neurosurgeon, threaded a tiny catheter through the patient’s femoral ... neck and into the brain. Once the catheter reached ...
(Date:7/10/2014)... 2014 Ticketability.com has a wide array of ... McCartney tickets for San Diego are being added to the ... 1976, and the newly added September 28 show is drawing ... Click Here to view the selection of discounted seats ... will become available to the general public on July 18 ...
(Date:7/10/2014)... July 11, 2014 According to ... Market by Platforms (Land, Airborne, Naval), Application (Software ... & by Geography (North America, Asia-Pacific, Europe, the ... (2014-2019)", published by MarketsandMarkets, the market is estimated ... expected to register a CAGR of 5.56% to ...
(Date:7/10/2014)... 2014 A Forever Recovery , ... clients off to a great start and gives them ... has launched a new Eating Disorders section of its ... highlights:, , Different types of eating ... Mental Disorders (DSM-IV), including anorexia nervosa, bulimia nervosa, and ...
Breaking Medicine News(10 mins):Health News:Netmail Heads to Washington, D.C. to Demonstrate New Release of Netmail 5.3 at WPC 2014 July 13-17, 2014 2Health News:Netmail Heads to Washington, D.C. to Demonstrate New Release of Netmail 5.3 at WPC 2014 July 13-17, 2014 3Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 2Health News:New Trial Delivers Chemotherapy to Brain Tumor Through Artery in Leg 3Health News:Paul McCartney Tickets for San Diego: Ticketability.com Announces Discounted Tickets for McCartney’s Tour Stop at Petco Park on September 28 2Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 2Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 3Health News:Portable Communication Systems Market Projected to Reach $39.52 Billion by 2019 - New Report by MarketsandMarkets 4Health News:Latest A Forever Recovery Launches Eating Disorders Section on Website 2
... designed to selectively weaken specific muscles may provide an ... attractive alternative treatment for frown lines, ... BFRM ) announced that it has acquired substantially ... Cosmetic Intervention,Inc. (ACI) and associated technology rights for $12 ...
... SpaBrite Teeth,Whitening System(TM) has introduced an FDA cleared ... the look of discolored teeth. The company,created the ... natural addition to the spa experience. Now the ... without compromising the effectiveness,of the treatment., The ...
... issued today by SEIU United Healthcare Workers-West:, In ... SEIU have launched a campaign, in the face of ... The most recent act of retaliation is their announcement ... board members created the,education fund in question in full ...
... YORK, April 29 It,s "Cover the ... attention on the nearly 47 million,Americans who ... this report from Pfizer (NYSE: PFE ... can access video, audio, text, graphics and,photos ...
... PITTSBURGH, April 29 Mylan Inc. (NYSE: ... Michael J. Monroe as senior vice,president - ... of the company,s senior,leadership team. In this ... and employee communications; corporate,branding/marketing; corporate media relations; ...
... or more of blood can be life-threatening , , ... that thicken the blood are highly effective in ... University of California, San Diego, bioengineering researchers. , ... standard emergency treatment for patients with severe bleeding. ...
Cached Medicine News:Health News:BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 2Health News:BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 3Health News:BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 4Health News:BioForm Medical Acquires Facial Aesthetic Nerve Ablation Technology 5Health News:Beautiful Teeth Not Just for the Dentist's Office Anymore / SpaBrite Teeth Whitening System(TM) Introduces Innovative, New Teeth Whitening Experience To Spas 2Health News:Statement by UHW President Sal Rosselli on SEIU Threat to Sue UHW Leaders 2Health News:Mylan Appoints Michael J. Monroe Senior Vice President for Global Public Affairs 2Health News:Viscosity Enhancers Curb Bleeding Complications 2
... EBV laboratory diagnosis is generally confirmed by a ... the disease however, is not indicated by the ... in 10 - 20 percent of children. ... necessary to fully ascertain the stage of EBV ...
... and Needle is specially designed to help ... quality, reliable core sample. All needles are ... and polished surfaces for smooth entry and ... and needle sizes assures an ideal match ...
... is designed to bring efficiency and quality ... combines the superior technology of fluorescent flow ... Continuous sampling or batch processing are ... sample processing in high volume laboratories. ...
... The IsoSleeve™ Source Delivery System incorporates ... design that provides the confidence that each ... prior to implant. Unlike other preloaded needle ... verification of the loading configuration giving you ...
Medicine Products: